Stichworte
Behandlungsbedürftigkeit, Begutachtung ×
Karzinom, hepatozelluläres ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

79 Suchergebnisse.

Eligibility Carcinoma, Hepatocellular NCT02421185

- 18.02.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Participants With Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02421185

Eligibility Carcinoma, Hepatocellular NCT02293850

- 18.02.19 - 1 Formular, 2 Itemgruppen, 34 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02293850

Eligibility Primary Hepatocellular Carcinoma NCT01563484

- 17.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media; ODM derived from: https://clinicaltrials.gov/show/NCT01563484

Eligibility Hepatocellular Carcinoma NCT02149771

- 16.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Combination Treatment for Advanced Liver Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02149771

Eligibility Hepatocellular Carcinoma NCT01759901

- 16.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01759901

Eligibility Hepatocellular Carcinoma NCT01492127

- 16.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01492127

Eligibility Hepatocellular Carcinoma NCT01392131

- 16.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01392131

Eligibility Hepatocellular Carcinoma NCT02299843

- 02.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
RALPPS Venus ALPPS for Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02299843

Eligibility Hepatocellular Carcinoma NCT01677468

- 02.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01677468

Eligibility Hepatocellular Carcinoma NCT01506115

- 02.01.19 - 1 Formular, 2 Itemgruppen, 7 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01506115

Eligibility Vitamin D Repletion in Patients with HCC o Transplant List NCT01575717 - Eligibility Vitamin D Repletion in Patients with HCC on Transplant List NCT01575717

- 07.09.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List; ODM derived from: https://clinicaltrials.gov/show/NCT01575717 Sponsor: Andrea Branch Information provided by (Responsible Party): Andrea Branch, Icahn School of Medicine at Mount Sinai Principal Investigator: Andrea D Branch, PhD Icahn School of Medicine at Mount Sinai

Eligibility Primary Hepatocellular Carcinoma NCT00966251

- 01.09.18 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00966251